Leukemia: all 5,475 studies
Page 41 of 55. Open to participants first (629), then studies with results posted, then the rest; newest registration first within each.
- Genome, Proteome and Tissue Microarray in Childhood Acute LeukemiaTerminatedNCT01108497
- Genetic Predictive Model Based on Single Nucleotide Polymorphisms in the DNA Repair Pathway and Drug Metabolis/Transport Pharmacogenetics in the Prediction of Response and Treatment Outcomes in Acute Myeloid LeukemiaStatus unknownNCT01106144
- Osteonecrosis in Children With Acute Lymphoblastic LeukemiaStatus unknownNCT01104324
- Antimicrobial Solution or Saline Solution in Maintaining Catheter Patency and Preventing Catheter-Related Blood Infections in Patients With MalignanciesWithdrawnNCT01101412Phase 1/2
- LFB-R603 Dose Finding in Patients With Advanced Stage B-Chronic Lymphocytic LeukemiaCompletedNCT01098188Phase 1
- Decitabine in Patients With Chronic Myelomonocytic Leukemia (CMML)CompletedNCT01098084Phase 2
- Pharmacokinetic Study of Doxorubicin in Children With CancerCompletedNCT01095926Phase 2
- Pharmacokinetic (PK) and Pharmacodynamic (PD) Study of Nelarabine in Patients With Relapsed/Refractory Lymphoid MalignanciesCompletedNCT01094860Phase 1
- Hemostasis During Asparaginase Treatment in Acute Lymphoblastic Leukemia(ALL)CompletedNCT01094392
- Late Chronic Phase Chronic Myelogenous LeukemiaCompletedNCT01092741Phase 2
- A Study of Clofarabine in Japanese Patients With Acute Myeloid Leukemia (AML)CompletedNCT01090167Phase 1
- Gamma-Secretase Inhibitor RO4929097 in Treating Young Patients With Relapsed or Refractory Solid Tumors, CNS Tumors, Lymphoma, or T-Cell LeukemiaTerminatedNCT01088763Phase 1
- A Study of ABT-263 in Combination With Dose-Intensive Rituximab, or Dose-Intensive Rituximab Alone, in Previously Untreated Patients With B-Cell, Chronic Lymphocytic Leukemia (CLL)CompletedNCT01087151Phase 2
- A Phase I Clinical Trial of OXi4503 for Relapsed and Refractory AML and MDSTerminatedNCT01085656Phase 1
- Standard Chemotherapy with or Without Nelarabine or Rituximab in Treating Patients with Newly Diagnosed Acute Lymphoblastic LeukemiaCompletedNCT01085617
- Connect™ CLL: The Chronic Lymphocytic Leukemia Disease RegistryCompletedNCT01081015
- Genome-wide Single Nucleotide Polymorphism (SNP) Array-based Approach to Predict Chemoresponse and Survival in Patients With Acute Lymphoblastic LeukemiaStatus unknownNCT01079507
- Presence of Donor-Derived DNA in Semen Samples From Cancer Survivors Who Underwent Donor Stem Cell TransplantTerminatedNCT01077440
- Biomarkers in Bone Marrow Samples From Pediatric Patients With High-Risk Acute Myeloid LeukemiaCompletedNCT01076569
- Cyclophosphamide, Alvocidib, and Rituximab in Treating Patients With High Risk B-Cell Chronic Lymphocytic Leukemia or Small Lymphocytic LymphomaTerminatedNCT01076556Phase 1
- Belinostat and Bortezomib in Treating Patients With Relapsed or Refractory Acute Leukemia or Myelodysplastic SyndromeCompletedNCT01075425Phase 1
- Discontinuation of Imatinib Mesylate in Patients With Chronic-Phase Chronic Myeloid Leukemia Previously Treated With Interferon-AlphaTerminatedNCT01073436
- An Observational Study on Infusion-related Adverse Events at Administration of MabThera (Rituximab) in Patients With Chronic Lymphocytic LeukemiaCompletedNCT01072240
- A Pediatric Study of a Plerixafor Containing Regimen In Second Allogeneic Stem Cell TransplantationCompletedNCT01068301Phase 1
- A Study Comparing Single Versus Double Umbilical Cord Blood Transplantation in the Young With Acute Leukemia RemissionStatus unknownNCT01067300Phase 3
- ALFA-0703 Study in Older Patients With Acute Myeloblastic Leukemia (AML)WithdrawnNCT01067274Phase 3
- A Pharmacokinetic and Efficacy Study of Amonafide L-malate (AS1413) in Combination With Cytarabine in Patients With Acute Myeloid Leukemia (AML)Status unknownNCT01066494Phase 2
- Glivec/Gleevec Pediatric (Age 1 to Less Than 4) PK Study in CML, Ph+ ALL Patients and Other Glivec/Gleevec® Indicated Hematological Disorders.TerminatedNCT01066468Phase 1
- Genome-wide Pharmacogenetic Candidate Gene Single Nucleotide Polymorphism (SNP) Array-based Approach to Predict Chemoresponse and Survival in Patients With Acute Myeloid Leukemia With Normal KaryotypeStatus unknownNCT01066338
- Genome Wide SNP Array-based Approach to Detect Micro-cytogenetic Lesions and KIT Mutation to Improve Treatment Outcomes in Patients With Core-binding Factor Positive Acute Myeloid LeukemiaStatus unknownNCT01066286
- The Role of Maintenance Oral Clofarabine in Older Adults With Acute Myeloid LeukemiaWithdrawnNCT01065545Phase 1
- AIDA 2000 GuidelinesStatus unknownNCT01064570Phase 2
- "AIDA" Protocol (LAP 0493)Status unknownNCT01064557Not applicable
- Treosulfan Based Conditioning Acute Myeloid Leukaemia (AML)CompletedNCT01063660Phase 2
- S9031-S9126-S9333-S9500-B Biomarker Expression in Patients With Acute Myeloid LeukemiaCompletedNCT01059734
- Studying Gene Expression in Tissue Samples From Young Patients With Acute Myeloid LeukemiaCompletedNCT01057303
- Studying Biomarkers in Cell Samples From Young Patients With Acute Myeloid LeukemiaCompletedNCT01057290
- Studying Biomarkers in Cell Samples From Patients With Acute Myeloid LeukemiaCompletedNCT01057199
- Studying Gene Expression in Tissue Samples From Patients With Acute Myeloid LeukemiaCompletedNCT01057095
- Fludarabine Phosphate, Busulfan, and Anti-Thymocyte Globulin Followed By Donor Peripheral Blood Stem Cell Transplant, Tacrolimus, and Methotrexate in Treating Patients With Myeloid MalignanciesCompletedNCT01056614Phase 2
- A Phase Ib, Open-label, Multi-center Dose-finding Study of Oral Panobinostat (LBH589) in Combination With Ara-C and Mitoxantrone as Salvage Therapy for Refractory or Relapsed Acute Myeloid LeukemiaCompletedNCT01055483Phase 1
- Massage Therapy Given by Caregiver in Treating Quality of Life of Young Patients Undergoing Treatment for CancerCompletedNCT01053494Not applicable
- Effect of Enteral Docosahexaenoic Acid Administration in Children With Acute Lymphoblastic LeukemiaCompletedNCT01051154Phase 2
- Dasatinib Combination for Chronic Lymphocytic Leukemia(CLL) With Refractory DiseaseStatus unknownNCT01051115Phase 2
- Autologous Hematopoietic Cell Transplantation for Core-binding Factor Acute Myeloid LeukemiaCompletedNCT01050036Not applicable
- Safety Study of ON 013105 in Lymphoma and Acute Lymphoid LeukemiaTerminatedNCT01049113Phase 1
- Targeted, Dose-Escalation Busulfan-Etoposide as Prep RegimenCompletedNCT01048827Phase 1
- Evaluation of Azacitidine in Transfusion Dependent Patients With Low-risk Myelodysplastic Syndrome (MDS) or Chronic Myelomonocytic Leukemia (CMML)CompletedNCT01048034Phase 2
- Motor Proficiency And Physical Activity in Adult Survivors of Childhood Acute Lymphoblastic Leukemia (ALL)CompletedNCT01047020
- Symptom Burden in Chronic Myeloid Leukemia (CML)Status unknownNCT01046305
- MSC and HSC Coinfusion in Mismatched MinitransplantsTerminatedNCT01045382Phase 2
- Precursor B Cell Acute Lymphoblastic Leukemia (B-ALL) Treated With Autologous T Cells Genetically Targeted to the B Cell Specific Antigen CD19Active, not recruitingNCT01044069Phase 1
- LAM07: Study to Analyze the Efficacy of a Risk Adapted Treatment Strategy, Including Gemtuzumab Ozogamicin (GO) During Consolidation, for Patients With Acute Myeloid Leukemia (AML)CompletedNCT01041040Phase 4
- Vorinostat Combined With Gemtuzumab Ozogamicin, Idarubicin and Cytarabine in Acute Myeloid LeukemiaStatus unknownNCT01039363Phase 2
- Donor-specific Allogeneic Hematopoietic Cell Transplantation for Acute Lymphoblastic Leukemia (ALL)TerminatedNCT01037764Phase 2
- PR104 in Treating Patients With Refractory/Relapsed Acute LeukemiaStatus unknownNCT01037556Phase 1/2
- A Study of Elacytarabine (CP-4055) Plus Idarubicin as Second Course Remission-Induction Therapy in Patients With Acute Myeloid LeukaemiaCompletedNCT01035502Phase 2
- Studying Biomarkers in Tissue Samples From Young Patients With Acute Myeloid Leukemia Previously Enrolled on Clinical Trial POG-9421CompletedNCT01035307
- A Phase I Study of GNKG168 in Patient With Relapsed or Refractory B-Cell Chronic Lymphocytic Leukemia (B-CLL)TerminatedNCT01035216Phase 1
- High-dose Cytarabine and Survival in AMLCompletedNCT01034839
- A Study of AS1411 Combined With Cytarabine in the Treatment of Patients With Primary Refractory or Relapsed Acute Myeloid LeukemiaTerminatedNCT01034410Phase 2
- Clofarabine, Cytarabine, and Filgrastim Followed by Infusion of Non-HLA Matched Ex Vivo Expanded Cord Blood Progenitors in Treating Patients With Acute Myeloid LeukemiaCompletedNCT01031368Phase 1
- B-type Chronic Lymphocytic Leukemia (B-CLL) Subgroups: Maturation Stage and Gene ExpressionCompletedNCT01030913
- Study to Assess OPB-31121 in Advanced Leukemias or Myelodysplastic SyndromesTerminatedNCT01029509Phase 1
- B Cell Repertoires in Chronic Lymphocytic Leukemia and AgingCompletedNCT01028430
- IV Plerixafor With Mitoxantrone Etoposide and Cytarabine for Acute Myeloid Leukemia (AML)TerminatedNCT01027923Phase 1
- Haploidentical Stem Cell Transplantation for Children With Therapy Resistant LeukemiaCompletedNCT01025778Phase 2
- Studying DNA in Blood and Bone Marrow Samples From Younger Patients With Acute Myeloid LeukemiaCompletedNCT01024127
- Donor Stem Cell Transplant or Bone Marrow Transplant in Treating Patients With Acute Myeloid Leukemia in RemissionCompletedNCT01020734Phase 2
- Allogeneic Stem Cell Transplantation Followed By Targeted Immune Therapy In Average Risk LeukemiaCompletedNCT01020539Phase 1
- Peripheral Blood (PB) Versus Bone Marrow (BM) in Allogeneic Stem Cell TransplantationCompletedNCT01020175Phase 3
- An Open Label, Single Centre Mass Balance C14 Study in Patients With Acute Myeloid Leukaemia (AML)CompletedNCT01019161Phase 1
- AEG35156 in Combination With High-dose Cytarabine and Idarubicin in AML Following Failure of a Single Standard Dose Cytarabine Based Frontline Induction RegimenTerminatedNCT01018069Phase 2
- Valproic Acid in Treating Patients With Previously Treated Non-Hodgkin Lymphoma, Hodgkin Lymphoma, or Chronic Lymphocytic LeukemiaStatus unknownNCT01016990Phase 2
- Studying DNA in Blood and Bone Marrow Samples From Young Patients With Acute Lymphoblastic LeukemiaCompletedNCT01016379
- Unrelated Double Umbilical Cord Blood Units TransplantationStatus unknownNCT01015742Phase 2/3
- Allogenic Bone Marrow Transplantation (BMT) Compare With Cytoreduction and Chemotherapy in Acute Lymphoblastic Leukemia (ALL) PatientsCompletedNCT01015261Phase 2/3
- Prospective Randomized Study Comparing One or Two High Dose Chemotherapy Regimen Followed by Autologous Stem Cell TransplantationCompletedNCT01015196Phase 2/3
- Risk of Psychopathology and Neurocognitive Impairment in Leukemia SurvivorsCompletedNCT01014195
- CD3/CD28 Bead Activated T-Cells Following Chemo-Immunotherapy in Patients With Chronic Lymphocytic LeukemiaCompletedNCT01013441Phase 1
- A Study of Imatinib and Valproic Acid in Patients With Chronic Myelogenous Leukemia (CML)WithdrawnNCT01011998Phase 2
- Safety and Efficacy Study of AS101 to Treat Elderly Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) PatientsSuspendedNCT01010373Phase 2
- The Expression of PTEN Protein and mRNA in Malignant Cells of Chronic Myelomonocytic LeukemiaTerminatedNCT01010256
- A Phase I Trial Using Cyclophosphamide, Rituximab and Revlimid (CR2) for the Treatment of Relapsed/Refractory B-Cell Chronic Lymphocytic Leukemia (B-CLL) and Small Lymphocytic Lymphoma (SLL)TerminatedNCT01005979Phase 1
- Combination Chemotherapy in Treating Adult Patients With Newly Diagnosed Acute Lymphoblastic LeukemiaStatus unknownNCT01005758Phase 2
- Study of Biomarkers in Blood and Bone Marrow Samples From Patients With Previously Untreated Chronic Lymphocytic LeukemiaCompletedNCT01005368
- Study of Biomarkers in DNA Samples From Patients With Acute Lymphoblastic Leukemia or Acute Myeloid LeukemiaCompletedNCT01005277
- Study of Bone Marrow and Blood Samples in Patients With Untreated Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia Enrolled on Clinical Trial CALGB-9621 or CALGB-9720CompletedNCT01004965
- Study of Blood and Bone Marrow Samples in Patients With Chronic Myelogenous Leukemia Enrolled on a CALGB Clinical TrialActive, not recruitingNCT01004640
- First-line Dasatinib Plus Conventional Chemotherapy in Adults With Newly Diagnosed Ph-Positive ALLCompletedNCT01004497Phase 2
- Autologous Transplantation for Chronic Myelogenous LeukemiaCompletedNCT01003054Phase 2
- Intravenous (IV) Decitabine and Oral Bexarotene for Acute Myelogenous Leukemia (AML)CompletedNCT01001143Phase 1
- Partially HLA-Matched Irradiated Allogeneic Cellular Therapy After Reduced Intensity Total Body IrradiationTerminatedNCT00996359Phase 1
- S9007, Study of Bone Marrow and Blood Samples From Patients With Leukemia or Other Hematopoietic CancersCompletedNCT00996047
- Disease Stabilization in AML by Treatment With ATRA, Valproic Acid and Low-dose CytarabineCompletedNCT00995332Phase 1/2
- Genetically Modified Haploidentical Natural Killer Cell Infusions for B-Lineage Acute Lymphoblastic LeukemiaCompletedNCT00995137Phase 1
- Methemoglobinemia in Young Patients With Hematologic Cancer or Aplastic Anemia Treated With DapsoneCompletedNCT00993694
- Leukemia Cell Cultures for Research of New Anti-Cancer TherapiesStatus unknownNCT00993538Not applicable
- Kidney Dysfunction in Children and Young Adults Who Have Received Methotrexate for Acute Lymphoblastic LeukemiaCompletedNCT00993135
- Liposomal Cytarabine for Central Nervous System (CNS)-Treatment in High-risk Acute Lymphoblastic Leukemia (ALL)SuspendedNCT00991744Phase 3